Á lódáil...
New-onset graves’ disease after the initiation of nivolumab therapy for gastric cancer: a case report
BACKGROUND: Immune checkpoint inhibitors (ICIs) can induce immune-related adverse events (irAEs) including thyroid dysfunction. There are only a few reports on Graves’ disease induced by ICIs. We report a case of new-onset Graves’ disease after the initiation of nivolumab therapy in a patient receiv...
Na minha lista:
| Foilsithe in: | BMC Endocr Disord |
|---|---|
| Main Authors: | , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BioMed Central
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7449083/ https://ncbi.nlm.nih.gov/pubmed/32847555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-020-00613-5 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|